. 1981 Jan;64(1):11-8.

Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy

R Rajatanavin et al. J Med Assoc Thai. 1981 Jan.

. 1981 Jan;64(1):11-8.

No abstract available

Similar articles

Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
Buerklin EM, Schimmel M, Utiger RD. Buerklin EM, et al. J Clin Endocrinol Metab. 1976 Aug;43(2):419-27. doi: 10.1210/jcem-43-2-419. J Clin Endocrinol Metab. 1976. PMID: 59733
Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
Yamada T, Koizumi Y, Sato A, Hashizume K, Aizawa T, Takasu N, Nagata H. Yamada T, et al. J Clin Endocrinol Metab. 1984 Apr;58(4):676-80. doi: 10.1210/jcem-58-4-676. J Clin Endocrinol Metab. 1984. PMID: 6421866
Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.
Wils JA, Kloppenborg PW. Wils JA, et al. J Clin Endocrinol Metab. 1970 Mar;30(3):406-7. doi: 10.1210/jcem-30-3-406. J Clin Endocrinol Metab. 1970. PMID: 4189571 No abstract available.
Concepts of pathogenesis of Graves' disease.
Solomon DH, Kleeman KE. Solomon DH, et al. Adv Intern Med. 1977;22:273-99. Adv Intern Med. 1977. PMID: 402796 Review. No abstract available.
[Toxic adenoma of the thyroid gland].
Schneck O, Eber O, Wascher H. Schneck O, et al. Wien Z Inn Med. 1966 Jul;47(7):261-77. Wien Z Inn Med. 1966. PMID: 4187164 Review. German. No abstract available.